Medicure (OTCMKTS:MCUJF) Posts Quarterly Earnings Results, Misses Expectations By $0.05 EPS

by · The Markets Daily

Medicure (OTCMKTS:MCUJF – Get Free Report) announced its earnings results on Friday. The company reported ($0.10) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.05) by ($0.05), Zacks reports. Medicure had a negative net margin of 21.65% and a negative return on equity of 44.34%.

Medicure Price Performance

OTCMKTS:MCUJF traded up $0.07 during mid-day trading on Friday, reaching $0.92. 101 shares of the company were exchanged, compared to its average volume of 3,744. Medicure has a 12 month low of $0.67 and a 12 month high of $0.97. The company has a fifty day moving average of $0.76 and a 200 day moving average of $0.81. The company has a quick ratio of 0.73, a current ratio of 1.04 and a debt-to-equity ratio of 0.03. The stock has a market cap of $9.55 million, a PE ratio of -1.95 and a beta of 0.99.

Medicure Company Profile

(Get Free Report)

Medicure Pharmaceutical Corp. is a specialty pharmaceutical company focused on the development, manufacturing and commercialization of therapies in the cardiovascular and critical‐care markets. The company advances its business through a combination of in-licensing, acquisitions and strategic partnerships designed to build a diversified portfolio of prescription products that address unmet medical needs.

Headquartered in Montreal, Canada, Medicure operates in North America and selectively in Europe through licensing agreements with regional distributors.

Featured Stories